Dew,
Your scenario could be plausible, however, it leaves the following out of the consideration: a weak data at the AACR. Then what? If ADXS decides to go ahead with the raise after the weak or not-so-great data is publicized, then the raise would result in a massive collapse of the share price. That would be a proverbial nail in the head. Raise from the position of weakness is a death sentence for us. Don't you agree?